Skip to main content

Extendicare Inc 5 Pct Debs(EXE-DB-C-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Extendicare Inc 5 Pct Debs up on Friday (EXE-DB-C)

Automated Summaries - The Globe and Mail - Fri May 3, 4:02PM CDT

Today, Extendicare Inc 5 Pct Debs opened at $98.60 and closed at $98.60. Intraday prices ranged from a low of $98.60 to a high of $98.60.

The price raised 0.10 percent from the previous day's close of $98.50.

During the day across North America, the TSX Composite closed 0.57% at 21947.41, the S&P 500 closed 0.91% at 5064.20, the Dow Jones Industrial Average closed 0.85% at 38225.66 and the Nasdaq Composite closed 1.51% at 15840.96.

Extendicare Inc 5 Pct Debs traded under EXE-DB-C on the Toronto Stock Exchange (TSX).

A total of 5,000 shares was traded during the session, with total trades of 2. On average, Extendicare Inc 5 Pct Debs has traded 52,600 shares over the last 5-days and 44,543 year-to-date.

The TSX market on the whole today saw 3,333 price advancers against 1,844 declines and 124 unchanged.

During the prior 52 weeks, EXE-DB-C.TO has traded as high as $99.50 (January 17,2024) and low as $92.50 (October 23,2023). Moreover, in the last 12 months, Extendicare Inc 5 Pct Debs's shares have gained 4.45%, while in 2024, they have gained 0.61%.

Following today's trading, Extendicare Inc 5 Pct Debs has a market capitalization of $0.00 on a float of 0 shares outstanding. Its annual EPS is $None.

Extendicare Inc 5 Pct Debs is a None company headquartered in, None.

Extendicare Inc 5 Pct Debs is holding an average recommendation of "Strong Sell" from 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe

inside the market
Short sales on the TSX: What bearish investors are betting against
Larry MacDonald